Survey of Edward Syndrome Screening in 25-35 Years Old Women with Polycystic Ovarian Syndrome and Treated in the Ardabil City in 2016
DOI:
https://doi.org/10.24200/jrset.vol5iss01pp14-17Abstract
edward syndrome screening in women 35-25 years old with polycystic ovary syndrome. Methodology: The statistical population is pregnant women in ardabil & sampling method is by census women who referred to a gynecologist. A sample of 100 35-25 year-old pregnant women, 50 pregnant women with no problems and 50 pregnant women with polycystic ovary syndrome were considered. The questionnaire contains information such as age, previous history of trisomy in the family and children, taking folic acid, marriage, parenthood, gestational age, history of smoking or alcohol, or take any other medicines, and was completed using interviews and extraction of office patient records. The results of the experiment answers were analyzed and and for data analysis using kolmogorov-smirnov test for normalization of the distribution of data and using pearson correlation test fir evaluate study hypotheses , the t test and statistical software , spss22, used in significance level of 05/0≥p . Results: The results show that average serum papp-a levels in mothers aged 35-25 with polycystic ovary syndrome under treatment in comparison with serum papp-a levels in the 35-25 year-old women with polycystic ovary syndrome and other mothers had a low level. The results show that average free β-hcg levels in mothers aged 35-25 with polycystic ovary syndrome under treatment in comparison with free β-hcg levels in the 35-25 year-old women with polycystic ovary syndrome and other mothers had a low level. The results show that average crl of mothers with polycystic ovary syndrome in comparison with crl of unaffected mothers for having a fetus with edwards syndrome has high level. Conclusion: The results show that none of the test used in this study has no chance for fetus affect by edward syndrome.References
Torabi, shirin, nasir, hemmatian, Mohammad. reporting one case Edward syndrome, ofogh danesh. Seasonal magazine of medical science and treatment health services on gonabad. 2001, duration17, no.4.
Karimi nezhad, Mohammad hosein . Chromosomal abnormalities, genetic in the third millennium. 2013, Issue 1.
Aitken, D.A. & Crossley JA. Screening for chromosome abnormalities. Current Obstetrics and Gynecology; 1992, 2: 65-71.
Kagan KO, Anderson JM, Anwandter G, Neksasova K, Nicolaides KH. Screening for triploidy by the risk algorithms for trisomies 21, 18 and 13 at 11 weeks to 13 weeks and 6 days of gestation. Prenat Diagn 2008; 28(13): 1209-13.
Leung TY, Chan LW, Leung TN, Fung TY, Sahota DS, Spencer K, et al. First-trimester combined screening for trisomy 21 in a predominantly Chinese population. Ultrasound Obstet Gynecol 2007; 29(1): 14-7.
Bruce R K. The genetic approach in pediatric medicine In: kligman, Behrman, Jenson: Nelson text book of pediatrics, 18th ed. Philadelphia: Sunders; 2007: 507.
Neidrist D, Riegel M, Acherman J. Survival with trisomy 18 data from switzerland . Am J Med Genet A 2006; 140(9): 952-959.
Goc B, walen cka Z, wlock A. Trisomy 18 in neonate: prenatal diagnosis, clinical features, therapeutic dilemmas and outcome. J appl Genet 2006; 47(2): 165-170.
